These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication. Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883 [TBL] [Abstract][Full Text] [Related]
6. Component-resolved diagnosis of baker's allergy based on specific IgE to recombinant wheat flour proteins. Sander I; Rihs HP; Doekes G; Quirce S; Krop E; Rozynek P; van Kampen V; Merget R; Meurer U; Brüning T; Raulf M J Allergy Clin Immunol; 2015 Jun; 135(6):1529-37. PubMed ID: 25576081 [TBL] [Abstract][Full Text] [Related]
7. Micro-arrayed wheat seed and grass pollen allergens for component-resolved diagnosis. Constantin C; Quirce S; Poorafshar M; Touraev A; Niggemann B; Mari A; Ebner C; Akerström H; Heberle-Bors E; Nystrand M; Valenta R Allergy; 2009 Jul; 64(7):1030-7. PubMed ID: 19210348 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Hohlfeld JM; Holland-Letz T; Larbig M; Lavae-Mokhtari M; Wierenga E; Kapsenberg M; van Ree R; Krug N; Bufe A Clin Exp Allergy; 2010 Jul; 40(7):998-1006. PubMed ID: 20412138 [TBL] [Abstract][Full Text] [Related]
9. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization. Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927 [TBL] [Abstract][Full Text] [Related]
10. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Dahl R; Stender A; Rak S Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194 [TBL] [Abstract][Full Text] [Related]
11. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Pullerits T; Lindén A; Malmhäll C; Lötvall J Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252 [TBL] [Abstract][Full Text] [Related]
12. Association of allergy-related symptoms with sensitisation to common allergens in an adult European population. Arshad SH; Karmaus W; Matthews S; Mealy B; Dean T; Frischer T; Tsitoura S; Bojarskas J; Kuehr J; Forster J; J Investig Allergol Clin Immunol; 2001; 11(2):94-102. PubMed ID: 11642579 [TBL] [Abstract][Full Text] [Related]
13. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis. Serrano E; Wahn HU; Didier A; Bachert C Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218 [TBL] [Abstract][Full Text] [Related]
15. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass. Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709 [TBL] [Abstract][Full Text] [Related]
16. Factors that affect the allergic rhinitis response to ragweed allergen exposure. Ellis AK; Ratz JD; Day AG; Day JH Ann Allergy Asthma Immunol; 2010 Apr; 104(4):293-8. PubMed ID: 20408338 [TBL] [Abstract][Full Text] [Related]